Anzeige
Mehr »
Login
Montag, 02.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Eilmeldung: Goldshores aggressiver Winter-Explorationsplan nimmt Gestalt an
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
245 Leser
Artikel bewerten:
(1)

Global Remifentanil Hydrochloride Market to Surpass USD 346.7 Mn By 2031| Growth Market Reports

Finanznachrichten News

PUNE, India, June 23, 2023 /PRNewswire/ -- According to a recent market study published by Growth Market Reports, titled, "Remifentanil Hydrochloride Market Segments - By Type (1mg/Vial,2mg/Vial,5mg/Vial) By Application (Endotracheal Intubation Operation, Neurosurgery, Outpatient surgery, Postoperative analgesia, Others) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region: Size, Share, Trends and Opportunity Analysis, 2023-2031", the market size was USD 272.2 Mn in 2022 and is expected to surpass USD346.7 Mn expanding at a CAGR of 2.8% by the end of 2031. The market is attributed to the rising number of surgical procedures and medical treatments.

Growth_Market_Reports_Logo1

Key Market Players Profiled in the Report

  • Teva Pharmaceutical Industries Ltd
  • Viatris Inc
  • Novartis AG (Sandoz International GmbH)
  • Fresenius SE & Co. KGaA
  • Hikma Pharmaceuticals PLC
  • B. Braun SE

Download PDF Sample here: https://growthmarketreports.com/request-sample/5252

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics. It provides an in-depth analysis of the market segments, which include types, application, distribution channel, and competitor analysis.

This report also includes a complete analysis of industry players and covers their latest developments, product portfolio, pricing, mergers, acquisitions, and collaborations. Moreover, it provides crucial strategies that are helping market players to expand their market share.

For Any Questions on This Report: https://growthmarketreports.com/enquiry-before-buying/5252

Regional Highlights:

On the basis of region, the global remifentanil hydrochloride market is classified as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is projected to dominate the global market, as there are high numbers associated with cases of chronic diseases in the region.

Europe is expected to be a rapidly growing region in the global market during the projected period, due to the rising demand for remifentanil hydrochloride in surgical treatments and procedures.

To Buy the Complete Report: https://growthmarketreports.com/report/remifentanil-hydrochloride-market-global-industry-analysis

Key Takeaways from the Study:

  • Remifentanil hydrochloride is an opioid analgesic medication that relieves pain during medical procedures or surgeries.
  • It is used to provide sedation and analgesia to ventilated patients under the supervision of skilled doctors & surgeons.
  • The technological advancements in the medical industry and increasing surgical procedures across the world is likely to boost the demand.
  • Growing research & development activities associated with remifentanil hydrochloride and its integration with other drug combinations are anticipated to create new pathways in the market.
  • The 1mg/Vial and 2mg/Vial segment refers to the one and two milligrams of the base form of remifentanil hydrochloride. This type is provided by numerous key players, thus driving the segment.
  • The Endotracheal Intubation Operation segment is projected to expand at the fastest CAGR during the forecast period, as remifentanil hydrochloride is popularly used in this surgery application, where the patient is completely unconscious.
  • The hospital pharmacies segment is anticipated to hold a major share of the market as it is a major medical dispenser and provider in the hospital setting.

Read 246 Pages Research Report with Detailed TOC on "Global Remifentanil Hydrochloride Market Segments - By Type (1mg/Vial,2mg/Vial,5mg/Vial) By Application (Endotracheal Intubation Operation, Neurosurgery, Outpatient surgery, Postoperative analgesia, Others) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region (North America, Asia Pacific, Europe, Latin America, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 - 2031"

Get Full Access to this Report: https://growthmarketreports.com/checkout/5252

Key Segments Covered

Type

  • 1mg/Vial
  • 2mg/Vial
  • 5mg/Vial

Application

  • Endotracheal Intubation Operation
  • Neurosurgery
  • Outpatient surgery
  • Postoperative analgesia
  • Others

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Other Related Reports:

  • Ventilator Test Systems Market Segments - by Types (Critical Care Ventilators, Neonatal Ventilators, and Transport & Portable Ventilators), Applications (Hospitals & Clinics, Home Care, Ambulatory Surgical Centers, and Emergency Medical Services), and Region (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa) -Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 - 2028
  • Global Sedation in ICU Setting Market by Type (Propofol, Dexmedetomidine, Remifentanil, Others), By Application (Neonatal Intensive Care Unit, Child Intensive Care Unit, Adult Intensive Care Unit) And By Region (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa), Forecast From 2022 To 2030
  • Global Patient-controlled Analgesic Infusion Pumps Market by Type (Syringe-Type, Cassette-Based Fluid Delivery Type), By Application (Hospitals, Clinics, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
  • Global Emergency Ventilator Market by Type (Volume-controlled ventilation modes, Pressure-controlled ventilation modes, Spontaneous breathing (non-invasive)), By Application (Adult, Child, Infant) And by Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030
  • About Growth Market Reports:

Growth Market Reports provides global enterprises as well as small & medium businesses with unmatched quality of "Market Research Reports" and "Industry Intelligence Solutions". Growth Market Reports has a targeted view to provide business insights and consulting to assist its clients in making strategic business decisions and achieving sustainable growth in their respective market domains.

Our key analysis segments, though not restricted to the same, include market entry strategies, market size estimations, market trend analysis, market opportunity analysis, market threat analysis, market growth/fall forecasting, primary interviews, and secondary research & consumer surveys.

Contact:
Alex Mathews
7th Floor, Siddh Icon,
Baner Road, Baner, Pune.
Maharashtra - 411045. India.
Phone: +1 909 414 1393
Email: sales@growthmarketreports.com
Web: https://growthmarketreports.com

Logo: https://mma.prnewswire.com/media/1980656/Growth_Market_Reports_Logo1.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/global-remifentanil-hydrochloride-market-to-surpass-usd-346-7-mn-by-2031-growth-market-reports-301860818.html

© 2023 PR Newswire
Nach Nvidia: 5 KI-Revolutionäre aus der zweiten Reihe!
Künstliche Intelligenz hat spätestens nach dem Raketenstart von Chat GPT das Leben aller verändert. Doch der Superzyklus steht nach Meinungen von Experten erst am Anfang. Während Aktien wie Nvidia von der ersten Aufwärtsentwicklung stark profitieren konnten, versprechen aussichtsreiche Player aus der

zweiten Reihe noch enormes Aufwärtspotenzial.

Im kostenlosen, exklusiven Spezialreport präsentieren wir ihnen 5 innovative KI-Unternehmen, die bahnbrechende Entwicklungen in diesem Sektor prägen könnten.

Warum sollten Sie dabei sein?
Trotz der jüngsten Erfolge steht die Entwicklung der künstlichen Intelligenz noch am Beginn eines neuen Superzyklus. Experten gehen davon aus, dass der Sektor bis 2032 global auf 1,3 Billionen US-Dollar explodieren wird, wobei ein großer Teil auf Hardware und Infrastruktur entfallen wird.

Nutzen Sie die Chance!
Fordern Sie sofort unseren brandneuen Spezialreport an und erfahren Sie, welche 5 KI-Aktien das größte Potenzial zur Vervielfachung besitzen. Dieser Report ist komplett kostenlos und zeigt Ihnen die aussichtsreichsten Investments im KI-Sektor.
Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.